Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 491, pseudogene (RNU6-491P) is a genomic locus classified as a pseudogene derived from the U6 small nuclear RNA gene family. Pseudogenes are segments of DNA that resemble functional genes but are generally considered non-functional due to mutations or lack of required regulatory elements for expression. However, some pseudogenes are transcribed and can participate in gene regulation, for example by producing non-coding RNAs that modulate parental gene expression via RNA interference or by acting as decoys for regulatory microRNAs[2][4]. The parental gene, U6 small nuclear RNA, is a highly conserved non-coding RNA essential for the spliceosome’s catalytic activity and mRNA splicing[1][3]. Pseudogenes like RNU6-491P typically do not produce functional RNA or protein and are thus not considered direct therapeutic targets. However, some pseudogenes in other gene families have been shown to participate in disease processes, especially by influencing the expression of related protein-coding genes or acting as competitive endogenous RNAs[2][4]. No specific molecular function, drug interaction, or clear biomarker role is currently assigned to RNU6-491P, and it is not considered a therapeutic target. The major issue with this entry is that it is a pseudogene—by definition non-functional as a protein or typical RNA gene—and thus does not fit the profile of classical drug targets such as receptors, enzymes, or channels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 491, pseudogene (RNU6-491P).